PPH Company Profile and Key Details

VanEck Pharmaceutical ETF (NASDAQ:PPH) closed at $109.60 USD, losing -$0.52 (-0.47%) from the previous close of $110.12. The stock is currently mid-range between its 52-week high and low $85.91 and $118.00. With a market capitalization of about $952.22 million, VanEck Pharmaceutical ETF is classified as a small-cap and shows lower-than-market volatility (beta ~0.41). Key stats such as the average daily volume over the past year has been around 266.40 thousand shares, volume is running light vs its 52-week average. Headquartered in New York, NY, VanEck Pharmaceutical ETF operates in the Financial Services sector and the Asset Management industry. VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Short-term trend indicators are bearishly aligned (SMA20 -0.03%, SMA50 2.82%, SMA200 15.85%). The stock’s 14-day RSI is 53.97 (neutral), while the ATR of 1.48 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -2.74% below its high and over 40.98% above its low. Average 10-day trading volume of 227.77 thousand shares is below the 3-month average of 267.40 thousand, indicating normal recent market interest.

VanEck Pharmaceutical ETF last paid a dividend of 2.17 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

currently trading near 52-week highs band.

Our AI price prediction model suggests that VanEck Pharmaceutical ETF stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.